One World Pharma Stock Fundamentals

OWPC Stock  USD 0.02  0.01  19.86%   
One World Pharma fundamentals help investors to digest information that contributes to One World's financial success or failures. It also enables traders to predict the movement of One OTC Stock. The fundamental analysis module provides a way to measure One World's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to One World otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

One World Pharma OTC Stock Return On Equity Analysis

One World's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current One World Return On Equity

    
  -4.13  
Most of One World's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, One World Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, One World Pharma has a Return On Equity of -4.133. This is 82.76% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is notably higher than that of the company.

One World Pharma Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining One World's current stock value. Our valuation model uses many indicators to compare One World value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across One World competition to find correlations between indicators driving One World's intrinsic value. More Info.
One World Pharma is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value One World by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for One World's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

One Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses One World's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of One World could also be used in its relative valuation, which is a method of valuing One World by comparing valuation metrics of similar companies.
One World is currently under evaluation in return on equity category among its peers.

One Fundamentals

About One World Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze One World Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of One World using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of One World Pharma based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
One World Products, Inc. intends to produce raw cannabis and hemp plant ingredients. One World Products, Inc. is headquartered in Las Vegas, Nevada. One World operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 31 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in One OTC Stock

One World financial ratios help investors to determine whether One OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in One with respect to the benefits of owning One World security.